No Pardon For Poor English in Science

Kiyokazu Agata decided to stay in Japan for his postdoctoral fellowship, and that decision haunts him today. Not because he hasn't been able to do great science in Japan--he's now a group director of evolutionary regeneration at the prestigious Center for Developmental Biology in Kobe. But his decision to forgo study overseas means that he never got a chance to excel in English. "English is essential for scientists. Going abroad is the best way to learn it," Agata says. "In my case, I missed t

Written bySam Jaffe
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Kiyokazu Agata decided to stay in Japan for his postdoctoral fellowship, and that decision haunts him today. Not because he hasn't been able to do great science in Japan--he's now a group director of evolutionary regeneration at the prestigious Center for Developmental Biology in Kobe. But his decision to forgo study overseas means that he never got a chance to excel in English. "English is essential for scientists. Going abroad is the best way to learn it," Agata says. "In my case, I missed the chance to study in foreign countries. It's my regret."

The ironic part is that Agata can speak and write English. He has studied the language since grammar school, but that's not good enough anymore. His lack of fluency keeps him from getting invitations to speak or present papers at international functions. It also makes it difficult to do collaborative projects with American or European colleagues. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies